Trial site
Encore Medical Research of Weston, LLC
Weston, Florida 33331, United StatesNot linked to an institution yet
- 14running trials
- 1closed trial
The trials here
What the 15 trials at this site are about, from their registry records.
- Phase
- Phase 37 trials
- Phase 23 trials
- Phase 12 trials
- Phase 2/32 trials
- Phase 41 trial
- Status
- Active, not recruiting7 trials
- Recruiting5 trials
- Enrolling by invitation2 trials
- Completed1 trial
- Lead sponsor
- Amgen4 trials
- Biohaven Therapeutics Ltd.3 trials
- Xenon Pharmaceuticals Inc.3 trials
- Gilead Sciences1 trial
- Insud Pharma1 trial
- and 3 more
Running trials
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
NCT07684144· Phase 3· Amgen· Source
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
NCT07684235· Phase 3· Amgen· Source
Recruiting
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
NCT07527923· Phase 1· Regeneron Pharmaceuticals· Source
Contact: Clinical Trials Administrator
Active, not recruiting
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
NCT07108283· Phase 2· Takeda· Source
Recruiting
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
NCT07051629· Phase 1· Suninflam Inc· Source
Contact: Ninett Llerena, RN
Active, not recruiting
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
NCT06858878· Phase 3· Amgen· Source
Active, not recruiting
Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
NCT06858839· Phase 3· Amgen· Source
Enrolling by invitation
Long-term Safety and Tolerability of BHV-7000
NCT06443463· Phase 2· Biohaven Therapeutics Ltd.· Source
Active, not recruiting
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
NCT06309966· Phase 2/3· Biohaven Therapeutics Ltd.· Source
Active, not recruiting
Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06290934· Phase 2· Gilead Sciences· Source
Active, not recruiting
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
NCT06132893· Phase 2/3· Biohaven Therapeutics Ltd.· Source
Enrolling by invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817· Phase 3· Xenon Pharmaceuticals Inc.· Source
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
NCT05667142· Phase 3· Xenon Pharmaceuticals Inc.· Source
Contact: Xenon Medical Affairs
Active, not recruiting
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
NCT05303636· Phase 4· Insud Pharma· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error